TherapeuticsMD - 15 Year Stock Price History | TXMD

Historical daily share price chart and data for TherapeuticsMD since 2011 adjusted for splits and dividends. The latest closing stock price for TherapeuticsMD as of September 18, 2026 is 2.19.
  • The all-time high TherapeuticsMD stock closing price was 550.00 on December 29, 2015.
  • The TherapeuticsMD 52-week high stock price is 2.95, which is 34.7% above the current share price.
  • The TherapeuticsMD 52-week low stock price is 0.99, which is 54.8% below the current share price.
  • The average TherapeuticsMD stock price for the last 52 weeks is 1.93.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
TherapeuticsMD Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 2.1358 1.6500 2.7700 1.6500 2.1900 34.36%
2025 1.1964 1.5700 1.9600 0.7300 1.6300 89.53%
2024 1.8646 2.3300 2.6900 0.8600 0.8600 -61.78%
2023 3.7247 6.2500 6.2500 2.0000 2.2500 -59.75%
2022 9.7822 19.5000 22.0000 2.0700 5.5900 -68.94%
2021 52.9802 62.0000 127.5000 18.0000 18.0000 -70.25%
2020 76.2312 122.0000 140.5000 43.5000 60.5000 -50.00%
2019 181.1766 194.0000 299.5000 93.5000 121.0000 -36.48%
2018 284.1853 313.5000 371.0000 178.0000 190.5000 -36.92%
2017 281.7390 298.5000 404.5000 192.0000 302.0000 4.68%
2016 357.4663 490.5000 490.5000 236.0000 288.5000 -44.36%
2015 331.3333 219.5000 550.0000 203.0000 518.5000 133.03%
2014 249.0675 249.5000 398.5000 171.5000 222.5000 -14.59%
2013 155.2123 162.5000 270.5000 85.0000 260.5000 68.06%
2012 134.1860 85.0000 175.0000 80.0000 155.0000 106.67%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.025B $0.003B
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.766B 23.37
Takeda Pharmaceutical (TAK) Japan $60.592B 11.26
UCB SA (UCBJY) Belgium $45.206B 0.00
BeOne Medicines - (ONC) Switzerland $38.518B 61.77
Otsuka Holdings, - (OTSKY) Japan $37.978B 14.20
Sandoz Group AG (SDZNY) Switzerland $36.696B 0.00
Daiichi Sankyo, - (DSNKY) Japan $35.209B 21.98
Zoetis (ZTS) United States $29.504B 10.85
Astellas Pharma (ALPMY) Japan $27.471B 9.09
United Therapeutics (UTHR) United States $21.215B 17.70
Merck (MKKGY) Germany $19.225B 15.34
Shionogi (SGIOY) Japan $15.862B 9.32
IPSEN (IPSEY) France $15.003B 0.00
Neurocrine Biosciences (NBIX) United States $14.864B 20.20
Summit Therapeutics (SMMT) United States $14.240B 0.00
Orion OYJ (ORINY) Finland $13.312B 19.41
Madrigal Pharmaceuticals (MDGL) United States $12.280B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Corcept Therapeutics (CORT) United States $11.922B 262.60
Eisai (ESAIY) $9.158B 0.00
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Ionis Pharmaceuticals (IONS) United States $7.385B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.572B 32.88
Oruka Therapeutics (ORKA) United States $6.287B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.975B 21.76
Definium Therapeutics (DFTX) United States $5.215B 0.00
Grifols, S.A (GRFS) Spain $4.975B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.129B 0.00
Indivior Pharmaceuticals (INDV) United States $4.117B 9.56
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Enliven Therapeutics (ELVN) United States $3.623B 0.00
Amylyx Pharmaceuticals (AMLX) United States $3.611B 0.00
Dyne Therapeutics (DYN) United States $3.195B 0.00
Hypermarcas (HYPMY) Brazil $3.172B 9.01
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.688B 0.00
Nektar Therapeutics (NKTR) United States $2.291B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.249B 16.57
Guardian Pharmacy Services (GRDN) United States $2.240B 42.44
BioCryst Pharmaceuticals (BCRX) United States $2.218B 5.99
Ocular Therapeutix (OCUL) United States $2.194B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Xencor (XNCR) United States $1.838B 0.00
KARDIGAN INC (KARD) United States $1.556B 0.00
Xeris Biopharma Holdings (XERS) United States $1.495B 117.14
Harrow (HROW) United States $1.240B 0.00
Cronos Group (CRON) Canada $1.235B 30.45
Apnimed (APMD) $1.207B 0.00
Aktis Oncology (AKTS) United States $1.176B 0.00
Seaport Therapeutics (SPTX) United States $1.145B 0.00
Savara (SVRA) United States $1.103B 0.00
Bioventus (BVS) United States $1.086B 16.99
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.974B 0.00
Avalo Therapeutics (AVTX) United States $0.889B 0.00
Theravance Biopharma (TBPH) United States $0.884B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.863B 11.90
Ardelyx (ARDX) United States $0.852B 0.00
4D Molecular Therapeutics (FDMT) United States $0.841B 0.00
Achieve Life Sciences (ACHV) Canada $0.821B 0.00
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.769B 0.00
Collegium Pharmaceutical (COLL) United States $0.741B 3.26
Silence Therapeutics (SLN) United Kingdom $0.735B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.720B 5.59
Zevra Therapeutics (ZVRA) United States $0.689B 7.35
OmniAb (OABI) United States $0.647B 0.00
Altimmune (ALT) United States $0.632B 0.00
Aquestive Therapeutics (AQST) United States $0.579B 0.00
ProKidney (PROK) United States $0.577B 0.00
Evotec AG (EVO) Germany $0.569B 0.00
Indaptus Therapeutics (INDP) United States $0.473B 0.00
Relmada Therapeutics (RLMD) United States $0.439B 0.00
ARS Pharmaceuticals (SPRY) United States $0.409B 0.00
Larimar Therapeutics (LRMR) United States $0.394B 0.00
Prelude Therapeutics (PRLD) United States $0.389B 0.00
Lexeo Therapeutics (LXEO) United States $0.345B 0.00
Avita Medical (RCEL) United States $0.339B 0.00
Century Therapeutics (IPSC) United States $0.337B 0.00
Inhibikase Therapeutics (IKT) United States $0.321B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
Lyell Immunopharma (LYEL) United States $0.270B 0.00
Elite Pharmaceuticals (ELTP) United States $0.267B 12.38
USANA Health Sciences (USNA) United States $0.261B 14.28
Galectin Therapeutics (GALT) United States $0.256B 0.00
Akebia Therapeutics (AKBA) United States $0.254B 0.00
Nature's Sunshine Products (NATR) United States $0.229B 11.13
Siga Technologies (SIGA) United States $0.226B 0.00
AleAnna (ANNA) United States $0.218B 17.21
Cardiol Therapeutics (CRDL) Canada $0.218B 0.00
Profound Medical (PROF) Canada $0.214B 0.00
Protara Therapeutics (TARA) United States $0.210B 0.00
Journey Medical (DERM) United States $0.206B 0.00
Surrozen (SRZN) United States $0.192B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.186B 0.00
Organogenesis (ORGO) United States $0.183B 0.00
Minerva Neurosciences (NERV) United States $0.175B 0.00
MediWound (MDWD) Israel $0.172B 0.00
Atrium Therapeutics (RNA) United States $0.153B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
NRx Pharmaceuticals (NRXP) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.140B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.134B 0.00
VAXART, INC (VXRT) United States $0.118B 3.04
Assertio Holdings (ASRT) United States $0.116B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
ElectroCore (ECOR) United States $0.105B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
PolyPid (PYPD) Israel $0.099B 0.00
Nutriband (NTRB) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
HST Global (HSTC) United States $0.092B 0.00
Telomir Pharmaceuticals (TELO) United States $0.085B 0.00
Aldeyra Therapeutics (ALDX) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.080B 0.00
Acrivon Therapeutics (ACRV) United States $0.079B 0.00
Gain Therapeutics (GANX) United States $0.077B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Champions Oncology (CSBR) United States $0.074B 0.00
Nuo Therapeutics (AURX) $0.063B 0.00
Talphera (TLPH) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.059B 0.00
Heron Therapeutics (HRTX) United States $0.059B 0.00
Veraxa Biotech AG (VRXA) United States $0.046B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.044B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Context Therapeutics (CNTX) United States $0.034B 0.00
Cosmos Health (COSM) United States $0.032B 0.00
Optimi Health (OPTH) Canada $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
Universe Pharmaceuticals INC (UPC) China $0.024B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Tempest Therapeutics (TPST) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Enlivex (ENLV) Israel $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00